Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia

International Journal of Hematology

Volumn 91, Issue 1, 2010, Pages 152-153

  Kobayashi, Yujin ^a   Hatta, Yoshihiro ^a   Ishizuka, Hikari ^a   Hirabayashi, Yukio ^a   Tanaka, Toshitake ^a   Takei, Kazuhiro ^a   Takeuchi, Jin ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; HEMOGLOBIN; IDARUBICIN; METHYLPREDNISOLONE; RETINOIC ACID;

AGED; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; DAILY LIFE ACTIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; JAPANESE; KIDNEY FAILURE; LENGTH OF STAY; LETTER; MENTAL HEALTH; MULTIPLE CYCLE TREATMENT; NEUTROPHIL; OUTPATIENT CARE; PANCYTOPENIA; PLEURA EFFUSION; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT;

AGED; ANTINEOPLASTIC AGENTS; ARSENICALS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES; REMISSION INDUCTION; TRETINOIN;

EID: 75049083318     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0470-7     Document Type: Letter

References (12)

1. MA Sanz D Grimwade MS Tallman B Lowenberg P Fenaux EH Estey, et al. 2009 Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Blood 113 9 1875 1891 10.1182/blood-2008-04-150250 1:CAS:528:DC%2BD1MXivVaqsLY%3D 18812465
2. SL Soignet SR Frankel D Douer MS Tallman H Kantarjian E Calleja, et al. 2001 United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia J Clin Oncol 19 18 3852 3860 1:CAS:528: DC%2BD3MXnsVKqsbY%3D 11559723
3. 3) on event free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710. J Clin Oncol. 2007 (ASCO Meeting Abstracts Part I):2.
4. E Estey G Garcia-Manero A Ferrajoli S Faderl S Verstovsek D Jones, et al. 2006 Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia Blood 107 9 3469 3473 10.1182/blood-2005-10-4006 1:CAS:528:DC%2BD28Xkt1Git7c%3D 16373661
5. F Ravandi E Estey D Jones S Faderl S O'Brien J Fiorentino, et al. 2009 Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin J Clin Oncol 27 4 504 510 10.1200/JCO.2008.18.6130 1:CAS:528:DC%2BD1MXivFyjtbY%3D 19075265
6. 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia Proc Natl Acad Sci USA 101 15 5328 5335 10.1073/pnas.0400053101 1:CAS:528:DC%2BD2cXjsVagt74%3D 15044693 (Pubitemid 38481160)
7. G Wang W Li J Cui S Gao C Yao Z Jiang, et al. 2004 An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid Hematol Oncol 22 2 63 71 10.1002/hon.728 15468344 (Pubitemid 39410010)
8. J Zhu V Lallemand-Breitenbach H de Thé 2001 Pathways of retinoic acid- or arsenic trioxide-induced PML/RARα catabolism, role of oncogene degradation in disease remission Oncogene 20 49 7257 7265 10.1038/sj.onc.1204852 1:CAS:528:DC%2BD3MXos1Onu7k%3D 11704854 (Pubitemid 33107375)
9. WY Au CS Chim AK Lie R Liang YL Kwong 2002 Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide Br J Haematol 117 1 130 132 10.1046/j.1365-2141.2002.03409.x 1:CAS:528:DC%2BD38XjvFGlsLc%3D 11918543 (Pubitemid 34304431)
10. M Sasaki K Sugimoto Y Isobe K Oshimi 2008 Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide Eur J Haematol 81 2 160 10.1111/j.1600-0609.2008. 01079.x 18363868 (Pubitemid 352019628)
11. A Ghavamzadeh K Alimoghaddam SH Ghaffari S Rostami M Jahani R Hosseini, et al. 2006 Treatment of acute promyelocytic leukemia without ATRA and/or chemotherapy Ann Oncol 17 1 131 134 10.1093/annonc/mdj019 1:STN:280: DC%2BD2MnntFKiug%3D%3D 16227315 (Pubitemid 43033852)
12. V Mathews B George KM Lakshmi A Viswabandya A Bajel P Balasubramanian, et al. 2006 Single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity Blood 107 7 2627 2632 10.1182/blood-2005-08-3532 1:CAS:528:DC%2BD28XjtlKltbs%3D 16352810